GONUTS has been updated to MW1.31 Most things seem to be working but be sure to report problems.
PMID:9388241
Citation |
Gray, MO, Karliner, JS and Mochly-Rosen, D (1997) A selective epsilon-protein kinase C antagonist inhibits protection of cardiac myocytes from hypoxia-induced cell death. J. Biol. Chem. 272:30945-51 |
---|---|
Abstract |
Protein kinase C activation is thought to protect cardiac tissue from subsequent ischemic injury by a process termed preconditioning. The protein kinase C isozyme that mediates preconditioning has not yet been identified. Using a cell culture model of hypoxic preconditioning, we found that cardiac myocyte viability after 9 h of hypoxia was increased by more than 50% over control. Preconditioning activated protein kinase C isozymes as evidenced by translocation from one cell compartment to another as follows: there was a 2.1-fold increase in epsilon-protein kinase C activation, a 2. 8-fold increase in delta-protein kinase C activation, and no increase in betaI-protein kinase C activation. 4beta-Phorbol 12-myristate 13-acetate mimicked hypoxic preconditioning, increasing myocyte survival after prolonged hypoxia by 34% compared with control. We previously identified an epsilon-protein kinase C-selective antagonist, epsilonV1-2 peptide, that inhibits epsilon-protein kinase C translocation and function in cardiac myocytes (Johnson, J. A., Gray, M. O., Chen, C.-H., and Mochly-Rosen, D. (1996) J. Biol. Chem. 271, 24962-24966). epsilonV1-2 peptide abolished hypoxic preconditioning and phorbol ester-mediated cardiac protection. Therefore, preconditioning can be induced in this culture model, and activation of epsilon-protein kinase C is critical for cardiac myocyte protection. |
Links | |
Keywords |
Animals; Biological Transport/drug effects; Cell Death/drug effects; Cell Hypoxia/drug effects; Cells, Cultured; Enzyme Activation/drug effects; Enzyme Inhibitors/pharmacology; HSP70 Heat-Shock Proteins/metabolism; Heart/drug effects; Ischemic Preconditioning, Myocardial; Isoenzymes/antagonists & inhibitors; Isoenzymes/physiology; Microscopy, Fluorescence; Myocardium/cytology; Peptide Fragments/pharmacology; Protein Kinase C/antagonists & inhibitors; Protein Kinase C/physiology; Protein Kinase C-epsilon; Rats; Tetradecanoylphorbol Acetate/pharmacology |
edit table |
Significance
Annotations
Gene product | Qualifier | GO Term | Evidence Code | with/from | Aspect | Extension | Notes | Status |
---|---|---|---|---|---|---|---|---|
GO:1990051: activation of protein kinase C activity |
ECO:0000314: |
P |
Figure 2 |
complete | ||||
See also
References
See Help:References for how to manage references in GONUTS.